Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced ...